223 related articles for article (PubMed ID: 25666769)
1. 5% lidocaine medicated plasters vs. sympathetic nerve blocks as a part of multimodal treatment strategy for the management of postherpetic neuralgia: a retrospective, consecutive, case-series study.
Malec-Milewska M; Horosz B; Sękowska A; Kolęda I; Kucia H; Kosson D
Neurol Neurochir Pol; 2015; 49(1):24-8. PubMed ID: 25666769
[TBL] [Abstract][Full Text] [Related]
2. [Experience with 5% lidocaine medicated plaster in the treatment of localized neuropathic pain].
Fogliardi A; Brunori C
Minerva Med; 2013 Dec; 104(6):631-7. PubMed ID: 24316916
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trial.
Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
Clin Drug Investig; 2009; 29(4):231-41. PubMed ID: 19301937
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy outcomes of long-term treatment up to 4 years with 5% lidocaine medicated plaster in patients with post-herpetic neuralgia.
Sabatowski R; Hans G; Tacken I; Kapanadze S; Buchheister B; Baron R
Curr Med Res Opin; 2012 Aug; 28(8):1337-46. PubMed ID: 22769236
[TBL] [Abstract][Full Text] [Related]
5. Sympathetic nerve blocks for the management of postherpetic neuralgia - 19 years of pain clinic experience.
Malec-Milewska M; Sękowska A; Kolęda I; Horosz B; Guć M; Jastrzębski J
Anaesthesiol Intensive Ther; 2014; 46(4):255-61. PubMed ID: 25293476
[TBL] [Abstract][Full Text] [Related]
6. 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study.
Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
Curr Med Res Opin; 2009 Jul; 25(7):1663-76. PubMed ID: 19485723
[TBL] [Abstract][Full Text] [Related]
7. 5% lidocaine-medicated plaster vs other relevant interventions and placebo for post-herpetic neuralgia (PHN): a systematic review.
Wolff RF; Bala MM; Westwood M; Kessels AG; Kleijnen J
Acta Neurol Scand; 2011 May; 123(5):295-309. PubMed ID: 21039364
[TBL] [Abstract][Full Text] [Related]
8. Impact of topical 5% lidocaine-medicated plasters on sleep and quality of life in patients with postherpetic neuralgia.
Binder A; Rogers P; Hans G; Baron R
Pain Manag; 2016; 6(3):229-39. PubMed ID: 26821240
[TBL] [Abstract][Full Text] [Related]
9. Effect of early stellate ganglion blockade for facial pain from acute herpes zoster and incidence of postherpetic neuralgia.
Makharita MY; Amr YM; El-Bayoumy Y
Pain Physician; 2012; 15(6):467-74. PubMed ID: 23159962
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of 5% lidocaine-medicated plasters in localized pain with neuropathic and/or inflammatory characteristics: an observational, real-world study.
Amato F; Duse G; Consoletti L; Lo Presti C; Firetto V; Ciliberto G; Parigi LA; Palmieri V; Mazza M
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4228-4235. PubMed ID: 29028074
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy.
Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
Curr Med Res Opin; 2009 Jul; 25(7):1677-87. PubMed ID: 19480610
[TBL] [Abstract][Full Text] [Related]
12. Topical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia: results of a double-blind, placebo-controlled, multinational efficacy and safety trial.
Binder A; Bruxelle J; Rogers P; Hans G; Bösl I; Baron R
Clin Drug Investig; 2009; 29(6):393-408. PubMed ID: 19432499
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: results of a long-term study.
Hans G; Sabatowski R; Binder A; Boesl I; Rogers P; Baron R
Curr Med Res Opin; 2009 May; 25(5):1295-305. PubMed ID: 19366301
[TBL] [Abstract][Full Text] [Related]
14. Lidocaine plasters for postherpetic neuralgia?
BMJ Group
Drug Ther Bull; 2008 Feb; 46(2):14-6. PubMed ID: 18256177
[TBL] [Abstract][Full Text] [Related]
15. Subcutaneous Injection of Triamcinolone and Lidocaine to Prevent Postherpetic Neuralgia.
Ni J; Wang X; Tang Y; Yang L; Zeng Y; Guo Y
Pain Physician; 2017 Jul; 20(5):397-403. PubMed ID: 28727702
[TBL] [Abstract][Full Text] [Related]
16. Effect of Repeated Paravertebral Injections with Local Anesthetics and Steroids on Prevention of Post-herpetic Neuralgia.
Makharita MY; Amr YM
Pain Physician; 2020 Nov; 23(6):565-572. PubMed ID: 33185373
[TBL] [Abstract][Full Text] [Related]
17. Post-herpetic neuralgia: 5% lidocaine medicated plaster, pregabalin, or a combination of both? A randomized, open, clinical effectiveness study.
Rehm S; Binder A; Baron R
Curr Med Res Opin; 2010 Jul; 26(7):1607-19. PubMed ID: 20429825
[TBL] [Abstract][Full Text] [Related]
18. Treatment of postherpetic neuralgia with 5% lidocaine medicated plaster in elderly patients - subgroup analyses from three European clinical trials.
Sabatowski R; Bösl I; König S; Buchheister B; Meier T; Baron R
Curr Med Res Opin; 2017 Mar; 33(3):595-603. PubMed ID: 28035844
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and impact on quality of life of post-herpetic neuralgia in French medical centers specialized in chronic pain management: the ZOCAD study.
Laurent B; Vicaut E; Leplège A; Bloch K; Leutenegger E
Med Mal Infect; 2014 Dec; 44(11-12):515-24. PubMed ID: 25455078
[TBL] [Abstract][Full Text] [Related]
20. Long-term treatment of neuropathic pain with a 5% lidocaine medicated plaster.
Wilhelm IR; Tzabazis A; Likar R; Sittl R; Griessinger N
Eur J Anaesthesiol; 2010 Feb; 27(2):169-73. PubMed ID: 20010108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
